The IMID Forum podcast

Author Interview: Doctor Mark Gibson, October 2026

27.10.2026
0:00
37:50
Spol 15 sekunder tilbage
Spol 15 sekunder frem
Join Professor Peter Nash from Griffith University in Brisbane and Doctor Mark Gibson from the Centre for Rheumatic Diseases, King’s College London, as they discuss Doctor Gibson’s recent paper, ‘Cancer risk of Janus kinase inhibitors and other advanced therapies in immune-mediated inflammatory diseases: a systematic review and Bayesian network meta-analysis of RCTs’.

Flere episoder fra "The IMID Forum"